Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02935621 · ClinicalTrials.gov registry record · NA

Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain

A NA study, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
230
Enrollment target

NCT02935621: Completed NA study, sponsored by University of Utah.

NCT02935621 is a NA study that has completed, run by University of Utah. The registered enrollment target is 230 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02935621, a NA study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
230 participants
Enrollment target

Study Summary

The central aim of this proposed study is to test a multimodal, mindfulness-oriented intervention designed to disrupt the risk chain leading to prescription opioid dose escalation, opioid misuse and opioid addiction, which are mounting threats to active duty service members and Veterans with chronic pain conditions, who may develop disordered opioid use as a consequence of long-term opioid pharmacotherapy.

Primary Outcome

Change in Current Opioid Misuse Measure from baseline through study completion (6 months post-treatment). Opioid misuse as evidenced by triangulated aggregate of Current Opioid Misuse Measure and/or clinician assessment via Addiction Behaviors Checklist and/or urine screen

Interventions

  • BEHAVIORAL Mindfulness-Oriented Recovery Enhancement (MORE)
  • BEHAVIORAL Support Group

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2017-04-01
Est. Completion 2022-12-15
Phase NA
University of Utah

818 total trials

What the finished NCT02935621 record still lists

NCT02935621 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness-Oriented Recovery Enhancement (MORE) is the first listed.

NCT02935621 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02935621 about?

NCT02935621 is a clinical study titled "Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain". The central aim of this proposed study is to test a multimodal, mindfulness-oriented intervention designed to disrupt the risk chain leading to prescription opioid dose escalation, opioid misuse and opioid addiction, which are mounting threats to active duty service members and Veterans with chronic...

What is the current status of trial NCT02935621?

This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2017-04-01. Estimated completion is 2022-12-15.

What interventions are being tested in trial NCT02935621?

The interventions under investigation include: Mindfulness-Oriented Recovery Enhancement (MORE) (BEHAVIORAL), Support Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02935621?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02935621's enrollment target sits among peer trials

230 465th of 2000 higher than 1,533 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02935621, the US trial registry maintained by the National Library of Medicine. NCT02935621 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.